Taiwan News9h
Rapid-Acting Insulin Market Growth Outlook, Revenue Forecast, and Trends (2020-2027)
However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...
pharmaphorum2d
First biosimilar fast-acting insulin reaches US market
Novo Nordisk's insulin aspart franchise is a DKK 10.6 billion ($1.5 billion) business worldwide, with NovoLog (known as NovoRapid outside the US) making up the bulk (around DKK 9 billion ...
pharmaphorum3d
This week in clinical trials: 20th to 24th May
Arecor Therapeutics’ (PDF) ultra-concentrated, ultra-rapid acting insulin candidate AT278 has ... accelerated PK/PD profile compared to NovoRapid and Humulin R U-500 in people with Type 2 ...
Canada3d
Universal Access to Contraception and Diabetes Medications and Increased Access to Diabetes Devices and Supplies, Canada-Yukon Funding Agreement
Between: His Majesty the King in Right of Canada, as represented by the Minister of Health (hereinafter referred to as "Canada") and: The Government of Yukon (hereinafter referred to as "Yukon") as ...